Max Kind

Background

About Max Kind

In my career with top companies, I found $47 million in operational waste that was invisible to everyone else. As Senior Manager for Data & BI/AI Product Tech, I led a team of 5+ professionals with a $3M+ budget. My job was finding the profit leaks that were draining millions from one of the world's largest pharmaceutical companies. What I discovered should terrify every venture-backed CEO: Over 24 months, I identified $47M in recoverable waste across commercial operations: • $1.2M monthly on duplicated AI initiatives nobody knew existed • $847K annually in decision-making bottlenecks fixable in 72 hours • $2.3M quarterly in unmeasured sales force inefficiencies • $8.2M total in "innovation theater"- projects that looked productive but created zero value Here's the uncomfortable truth: If Fortune 10 companies with unlimited resources miss these leaks, what are venture-backed companies missing? I now help venture-backed CEOs discover their hidden profit leaks before their boards or competitors find them first. The same operational intelligence that recovered $47M at J&J works even better at venture scale - you just need to know where to look. Currently working with 8 venture-backed companies in Q3. Ready to discover what's hiding in your operations? Send me a message - I'll show you the 3 questions that exposed J&J's biggest profit leaks- Key Achievements: Recovered $47M in operational waste Led 30+ person team with $5M+ budget in AI/Data product development Identified $5.2M annual waste at Sterling Check (before McKinsey audit) 15+ years Fortune 10 commercial operations experience Specialized in venture-backed biotech/pharma operational audits